Synopsis
The SCI’s Fine Chemicals Group and the RSC’s Applied Catalysis Group are pleased to announce this one-day biennial symposium - Challenges in Catalysis for Pharmaceuticals and Fine chemicals VII. The aim of this meeting, well-supported both by industry and academia is to debate the current developments in catalysis, where they are going and what industry needs. An exciting line up of leading academic and industrial scientists will present a series of lectures covering topics in homogeneous, heterogeneous and enzymatic catalysis.
Attendees
This meeting is suitable for all organic/medicinal chemists (students, early and mid-career) working in academia and industry and chemical engineers in process development.
Programme
Tuesday 19 November 2024
- 10.00
- Registration and refreshments
- 10.30
- Introduction and welcome
- 10.35
- Past and current trends in catalysis – what does the future hold?
Dr Carin Seechurn, Sinocompound
- 11.25
- Enantioselective base metal catalysis: from organometallic chemistry to engineered enzymes
Professor Xile Hu, Ecole Polytechnique Fédérale de Lausanne
- 12.15
- Lunch, posters and exhibition
- 13.45
- Catalysts for pharma scale continuous hydrogenation
Lee Edwards, GSK
- 14.35
- Biocatalytic hydrogenation: Robust biotechnologies for sustainable chemical manufacturing
Dr Sarah Cleary, HydRegen
- 15.25
- Refreshments, posters and exhibition
- 15.55
- Pharmaceutical industry perspectives on biocatalysis
Greg Mann, Novartis
- 16.45
- Innovative concepts and catalysts for the formation of C-C and C-heteroatom bonds
Professor Lukas Gooßen, Ruhr-Universität Bochum
- 17.35
- Closing remarks
- 17.40
- Wine reception
SCI’s Fine Chemicals Group are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with full inclusivity where attendees from all backgrounds are welcome. We are open to offering flexible presentation options.
Accessibility Grants
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Call for posters
If you would like to present a poster, please send an abstract of maximum one A4 page or up to 300 words, indicating title and authors, to conferences@soci.org by Wednesday 25 September 2024 with the subject line “Challenges in Catalysis VIII – poster abstract submission”. You can download an abstract template here.
Exhibition and Sponsorship
An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please click here for the pack and email conferences@soci.org letting us know which package you are interested in. Spaces are limited and will be allocated on a first-come, first-served basis.
Venue and Contact
Fees
Early bird - ends Tuesday 8 October 2024
SCI/RSC* Member - £120
Non-member - £140
SCI/RSC** Student member - £35 |
After early bird
SCI/RSC* Member - £170
Non-member - £195
SCI/RSC** Student member - £50
|
*RSC members should enter the Event discount code EJRFCHEM678 and select “Guest Member” under the section Member type. Delegates will be contacted for their RSC membership number after successful registration.
**RSC student members should enter the Event discount code EJRFCHEM678S and select “Guest Member” under the section Member type. Delegates will be contacted for their RSC membership number after successful registration.
All registrations will automatically receive a confirmation within 24 hours of registering for the event. Should you not receive written confirmation of your booking, please email conferences@soci.org.
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
Booking terms and conditions
ORGANISING COMMITTEE
Emmanuel Callens, 30Technology (SCI)
Amanda Jarvis, University of Edinburgh (RSC)
Sam Staniland, AstraZeneca (RSC)
Katherine Wheelhouse, GSK (RSC)